Collectively, our results suggest that the S protein-exerted EC damage overrides the decreased virus infectivity. This conclusion suggests that vaccination-generated antibody and/or exogenous antibody against S protein not only protects the host from SARS-CoV-2 infectivity but also inhibits S protein-imposed endothelial injury.
You got that from the Salk paper (that was linked) that I specifically referred to?
I looked, again, and I still don’t see it...or, any mention of the shots, at the link.
It’s getting late and my eyes might be missing it, though ;-)